See more : Scout Security Limited (SSECF) Income Statement Analysis – Financial Results
Complete financial analysis of Lescarden Inc. (LCAR) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Lescarden Inc., a leading company in the Biotechnology industry within the Healthcare sector.
- Top Strike Resources Corp. (TPPRF) Income Statement Analysis – Financial Results
- Syncom Formulations (India) Limited (SYNCOMF.BO) Income Statement Analysis – Financial Results
- Sylph Technologies Limited (SYLPH.BO) Income Statement Analysis – Financial Results
- Guangdong High Dream Intellectualized Machinery Co., Ltd. (300720.SZ) Income Statement Analysis – Financial Results
- Helia Group Limited (GMA.AX) Income Statement Analysis – Financial Results
Lescarden Inc. (LCAR)
About Lescarden Inc.
Lescarden Inc. researches, tests, develops, and sells medications for the control and cure of various diseases in the United States, Europe, and South Korea. Its lead product is Catrix Wound Dressing for the management of chronic lesions and burns, as well as for non-healing wounds, including decubitus ulcers, venous stasis ulcers, and diabetic ulcers. The company also offers a line of Catrix-based wound and skin care products for the plastic surgery, dermatology, and medical spa markets. In addition, it provides nutritional supplements, such as Bio-Cartilage and Poly-NAG, a patented glucosamine polymer; and licenses its technologies for commercialization by other companies. Lescarden Inc. was founded in 1960 and is based in New York, New York.
Source: https://incomestatements.info
Category: Stock Reports